Departamento de Medicina Interna, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
Am J Emerg Med. 2012 Nov;30(9):1991-9. doi: 10.1016/j.ajem.2012.04.033. Epub 2012 Jul 15.
The aim of the study was to determine whether C-reactive protein (CRP), procalcitonin (PCT), and d-dimer (DD) are markers of mortality in patients admitted to the emergency department (ED) with suspected infection and sepsis.
We conducted a prospective cohort in a university hospital in Medellín, Colombia. Patients were admitted between August 1, 2007, and January 30, 2009. Clinical and demographic data and Acute Physiology and Chronic Health Evaluation II and Sepsis Organ Failure Assessment scores as well as blood samples for CRP, PCT, and DD were collected within the first 24 hours of admission. Survival was determined on day 28 to establish its association with the proposed biomarkers using logistic regression and receiver operating characteristic curves.
We analyzed 684 patients. The median Acute Physiology and Chronic Health Evaluation II and Sepsis Organ Failure Assessment scores were 10 (interquartile range [IQR], 6-15) and 2 (IQR, 1-4), respectively. The median CRP was 9.6 mg/dL (IQR, 3.5-20.4 mg/dL); PCT, 0.36 ng/mL (IQR, 0.1-3.7 ng/mL); and DD, 1612 ng/mL (IQR, 986-2801 ng/mL). The median DD in survivors was 1475 ng/mL (IQR, 955-2627 ng/mL) vs 2489 ng/mL (IQR, 1698-4573 ng/mL) in nonsurvivors (P=.0001). The discriminatory ability showed area under the curve-receiver operating characteristic for DD, 0.68; CRP, 0.55; and PCT, 0.59. After multivariate analysis, the only biomarker with a linear relation with mortality was DD, with an odds ratio of 2.07 (95% confidence interval, 0.93-4.62) for values more than 1180 and less than 2409 ng/mL and an odds ratio of 3.03 (95% confidence interval, 1.38-6.62) for values more than 2409 ng/mL.
Our results suggest that high levels of DD are associated with 28-day mortality in patients with infection or sepsis identified in the emergency department.
本研究旨在确定 C 反应蛋白(CRP)、降钙素原(PCT)和 D-二聚体(DD)是否可作为疑似感染和脓毒症患者急诊就诊时死亡率的标志物。
我们在哥伦比亚麦德林的一所大学医院进行了一项前瞻性队列研究。患者于 2007 年 8 月 1 日至 2009 年 1 月 30 日期间入院。在入院后的 24 小时内采集临床和人口统计学数据、急性生理学和慢性健康评估 II 以及脓毒症器官衰竭评估评分以及 CRP、PCT 和 DD 的血样。通过逻辑回归和接收者操作特征曲线确定第 28 天的生存情况,以确定其与所提出的生物标志物的关系。
我们分析了 684 名患者。急性生理学和慢性健康评估 II 以及脓毒症器官衰竭评估的中位数评分分别为 10(四分位距[IQR],6-15)和 2(IQR,1-4)。CRP 的中位数为 9.6mg/dL(IQR,3.5-20.4mg/dL);PCT,0.36ng/mL(IQR,0.1-3.7ng/mL);DD,1612ng/mL(IQR,986-2801ng/mL)。幸存者的 DD 中位数为 1475ng/mL(IQR,955-2627ng/mL),而非幸存者为 2489ng/mL(IQR,1698-4573ng/mL)(P<.0001)。区分能力显示 DD 的曲线下面积-接收者操作特征为 0.68;CRP 为 0.55;PCT 为 0.59。多变量分析后,唯一与死亡率呈线性关系的生物标志物是 DD,其比值比(OR)为 2.07(95%置信区间[CI],0.93-4.62),值大于 1180 且小于 2409ng/mL,OR 为 3.03(95%CI,1.38-6.62),值大于 2409ng/mL。
我们的结果表明,DD 水平升高与急诊科确诊的感染或脓毒症患者 28 天死亡率相关。